AC Immune SA (ACIU)
2.12
-0.02
(-0.93%)
USD |
NASDAQ |
Nov 13, 16:00
2.12
0.00 (0.00%)
After-Hours: 19:59
AC Immune EPS Diluted (Quarterly) : -0.16 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.16 |
| June 30, 2026 | 0.026 |
| March 31, 2026 | -0.2078 |
| December 31, 2025 | -0.1778 |
| September 30, 2025 | -0.1964 |
| June 30, 2025 | -0.2546 |
| March 31, 2025 | -0.2108 |
| December 31, 2024 | -0.1802 |
| September 30, 2024 | 0.063 |
| June 30, 2024 | -0.2528 |
| March 31, 2024 | -0.2055 |
| December 31, 2023 | -0.0578 |
| September 30, 2023 | -0.2023 |
| June 30, 2023 | -0.2213 |
| March 31, 2023 | -0.2263 |
| December 31, 2022 | -0.2326 |
| September 30, 2022 | -0.1672 |
| June 30, 2022 | -0.2409 |
| March 31, 2022 | -0.2444 |
| December 31, 2021 | -0.2841 |
| September 30, 2021 | -0.2378 |
| June 30, 2021 | -0.288 |
| March 31, 2021 | -0.2554 |
| December 31, 2020 | -0.30 |
| September 30, 2020 | -0.2871 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.2272 |
| March 31, 2020 | -0.1105 |
| December 31, 2019 | -0.2734 |
| September 30, 2019 | 0.2556 |
| June 30, 2019 | -0.2382 |
| March 31, 2019 | 0.9086 |
| December 31, 2018 | -0.2182 |
| September 30, 2018 | -0.2118 |
| June 30, 2018 | -0.1928 |
| March 31, 2018 | -0.2109 |
| December 31, 2017 | 0.0709 |
| September 30, 2017 | -0.1558 |
| June 30, 2017 | -0.2236 |
| March 31, 2017 | -0.1694 |
| December 31, 2016 | -0.0799 |
| September 30, 2016 | -0.1845 |
| June 30, 2016 | 0.2701 |
| March 31, 2016 | -0.1122 |
| December 31, 2015 | -0.1009 |
| September 30, 2015 | 0.4458 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Precigen, Inc. | 0.0849 |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| Aldeyra Therapeutics, Inc. | -0.0624 |
| BeOne Medicines Ltd. | 3.288 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.77M |
| Revenue (Quarterly) | 3.994M |
| Total Expenses (Quarterly) | 14.77M |
| Enterprise Value | 111.10M |
| Profit Margin (Quarterly) | -269.7% |
| Earnings Yield | -24.51% |